Radx-tech- support services needed for work package 1
Ended Purchase Order Awarded Last action
- Contract number
- 75N92021P00050
- Awardee
-
Novel Microdevices, Inc. UEI THEXFPSLGYN1
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $250,000
Award facts
- Contract value 100% obligated
- $250,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21202, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Original award | $250,000 |
About this award
Novel Microdevices, Inc. (doing business as Novel Devices) was awarded a firm fixed-price purchase order valued at $250,000 by the National Heart Lung and Blood Institute (NHLBI) on January 19, 2021, for RADX-Tech support services under Work Package 1. The contract, which is not set aside for any socioeconomic program, has an ultimate completion date of January 18, 2022, and will be performed in East Case, Maryland. As a civilian agency contract, this award falls under the National Institutes of Health's Rapid Acceleration of Diagnostics (RADx) initiative, which focuses on advancing diagnostic technologies and capacity to detect COVID-19 and other infectious diseases.
The RADX-Tech component of this program specifically supports the development and implementation of diagnostic technologies and related infrastructure. Novel Microdevices' role as a support services provider under Work Package 1 likely contributes to technical assistance, development support, or implementation activities related to diagnostic device innovation and deployment efforts. The firm fixed-price structure provides cost certainty for the government while enabling focused execution of the defined scope of work within the one-year performance period.
Quick answers
Who was awarded contract 75N92021P00050?
75N92021P00050 was awarded to Novel Microdevices, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on January 19, 2021.
How much is contract 75N92021P00050 worth?
The government has obligated $250,000 on 75N92021P00050.
Was contract 75N92021P00050 competed?
The extent of competition for 75N92021P00050 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award